CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $1.3M invested in Can-Fite BioPharma in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

29% less capital invested

Capital invested by funds: $1.84M → $1.3M (-$539K)

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$161K
2
+$34.7K
3
+$1K

Top Sellers

1
-$225K
2
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$471K
2
$448K
3
$358K
4
$12K
5
$7K
6
$3K
7
$1K
8
–